Researchers portal

Portal del personal investigador

Searching. Please wait…

Portal del Investigador > en > Publications > publication-detail

Detalle_Publicacion

Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes'"

Other publications of the same journal or congress with authors from the University of Cantabria

Secukinumab is effective and safe in the treatment of recalcitrant palmar-plantar psoriasis and palmar-plantar pustular psoriasis in a daily practice setting - Conference object
Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS) - Article
Interruption of Oral Clindamycin Plus Rifampicin Therapy in Patients With Hidradenitis Suppurativa: An Observational Study to Assess Prevalence and Causes - Article

Fuente: Journal of the American Academy of Dermatology, 2023, 88(5), e271-e27

Publisher: Elsevier

Year of publication: 2023

No. of pages: 2

Publication type: Article

DOI: 10.1016/j.jaad.2019.03.006

ISSN: 0190-9622,1097-6787

Publication Url: https://doi.org/10.1016/j.jaad.2019.03.006

Read publication

Authorship

SCHNELLER-PAVALESCU, LUCA

VERGARA-DE CASO, EDUARDO

MARTORELL, ANTONIO

ROMANÍ, JORGE

LÁZARO, MIREYA

VILARRASA, EVA

DÍAZ-LEY, BLANCA

VÁZQUEZ-OSORIO, IGOR

SEGURA PALACIOS, JUAN MANUEL

AZAÑA, JOSÉ MANUEL

MARCOS ANTONIO GONZALEZ LOPEZ

CAÑUETO, JAVIER

MOLINA-LEYVA, ALEJANDRO

LEIVA-SALINAS, MARÍA

NAVARRO-TRIVIÑO, FRANCISCO JOSÉ

SÁNCHEZ-PAYÁ, JOSÉ

PASCUAL, JOSÉ C.

Download reference

Bib Ris